← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2016Last known activity
Oct 21, 2025
Timeline
2000s
- Apr 1, 2004
Zymeworks Inc.— Founded
2010s
- Mar 22, 2016
Compass Therapeutics— Acquired
Drugs by trial phase (28 distinct, 18 trials)
Phase 3 (14 own, 2 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (24)
- NCT04578444Lead sponsorN/A—
- NCT07164313OfficialPhase 1Oct 21, 2025
- NCT07164313Lead sponsorPhase 1Oct 21, 2025
- NCT06555744OfficialPhase 1Oct 30, 2024
- NCT06555744Lead sponsorPhase 1Oct 30, 2024
- NCT06523803Lead sponsorPhase 1Sep 30, 2024
- NCT06523803OfficialPhase 1Sep 30, 2024
- NCT05615818CollaboratorPhase 3Jul 18, 2024
- NCT05152147Study directorPhase 3Dec 31, 2021
- NCT05152147Lead sponsorPhase 3Dec 31, 2021
- NCT05035836CollaboratorPhase 2Oct 15, 2021
- NCT05027139Lead sponsorPhase 1/Phase 2Sep 15, 2021
- NCT05027139Study directorPhase 1/Phase 2Sep 15, 2021
- NCT04466891Lead sponsorPhase 2Oct 1, 2020
- NCT04466891Study directorPhase 2Oct 1, 2020
Details
- Founded
- Vancouver, BC, CA Apr 1, 2004
- Last known activity
- Oct 21, 2025